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Abstract
Background: There is limited population-based data on diet and physical activity behaviors and
weight loss among users of prescription weight loss medications. Most findings are from clinical
settings or from research that includes organized behavioral programs.
Methods: We analyzed data from the 1998 Behavioral Risk Factor Surveillance System, an annual
telephone survey conducted in all fifty states, the District of Columbia and Puerto Rico. The sample
consisted of 135,435 noninstitutionalized adults aged 18 years old and older. We determined the
prevalence and odds of prescription weight loss medication use, odds of 10% weight loss, and
among current weight loss medication users, the prevalence and odds for diet and physical activity
behaviors.
Results: 10.2% of obese women and 3.1% of obese men reported using prescription weight loss
medications in the past 2 years. Of users, 28.2% had lost at least 10% of their pretreatment body
weight. The odds of losing at least this much weight were higher among women, those who usually
consumed ≥ 5 fruits and vegetables daily and those who met physical activity recommendations.
Among current prescription weight loss medication users, 26.7% reported both eating fewer
calories and meeting recommended leisure-time physical activity levels (<40% of any group met
both). Of those meeting both recommendations, almost half (47.2%) had lost 10% of their
pretreatment body weight. Of current users, 9% reported using the medications for weight
maintenance.
Conclusions:  Only 26.7% of prescription weight loss medication users reported following
recommended diet and physical activity behaviors. Further research is needed to assess whether
behavioral changes are associated with greater weight loss and maintenance among prescription
weight loss medication users.
Background
Lifestyle modifications, including behavior therapy, diet,
and physical activity, are the cornerstone of weight man-
agement [1]. Current weight management guidelines state
that prescription weight loss medication only may be used
as part of a comprehensive weight loss program including
diet and physical activity modifications [1]. These modifi-
cations include increasing physical activity to 30 to 45
minutes on most days of the week and reducing daily
caloric intake by 500 to 1000 calories. Clinical research
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also suggests that increasing consumption of whole
grains, fruits, and vegetables in place of calorie-dense
foods may increase satiety and decrease overall caloric
intake aiding weight management [2].
The initial goal of weight loss therapy is to reduce body
weight by approximately 10% over a 6-month period [1].
Even small losses in weight, such as 5% to 10%, have been
found to reduce blood pressure, cholesterol and triglycer-
ides levels, and reduce blood glucose levels among over-
weight and obese persons without diabetes [3,4]. Weight
loss attributable to prescription weight loss drugs is mod-
est, about 3% to 8% of body weight, and is based on a
small number of patients assigned to drug treatment in
clinical trials [5-8]. Lifestyle modification in combination
with pharmacotherapy has been shown to improve
weight loss more effectively than pharmacotherapy alone
[9]. However, in the general population, data suggests that
only one-fifth of individuals who were trying to lose
weight reported using the recommended combination of
eating fewer calories and meeting weekly physical activity
recommendations [10].
Using population-based data we estimated that 4.6 mil-
lion American adults used prescription weight loss medi-
cations between 1996 and 1998 [11]. During this period,
obesity medications included phentermine, fenfluramine,
dexfenfluramine, and sibutramine. Because of the paucity
of population-based data on behaviors among persons
using prescription weight loss medications, the purpose of
our study was to further examine demographic and
behavioral characteristics related to the reported use of
prescription weight loss medications collected in the late
1990s as part of a national dataset. These data were col-
lected the same year as issuance of guidelines for assess-
ment and treatment of obesity and therefore provide
baseline estimates. Specifically, we examined 1) prescrip-
tion weight loss medication use by demographic and
behavioral characteristics, 2) 10% weight loss among pre-
scription weight loss medication users by demographic
and behavioral characteristics, and 3) diet and physical
activity behaviors among those who used prescription
weight loss medications at the time of the survey.
Methods
We examined data from the 1998 Behavioral Risk Factor
Surveillance System (BRFSS). The BRFSS is a telephone
survey of health practices that is conducted each year by
all state health departments. Each state, the District of
Columbia, and Puerto Rico select an independent proba-
bility sample of noninstitutionalized residents aged 18
years and older. In 1998, 149,806 persons responded to
the BRFSS; several investigators have published detailed
descriptions of survey methods and quality control indi-
ces [12]. The average 1998 state cooperation rate (com-
pleted interviews divided by completed, refused, and
terminated interviews) was 73.4% (range, 45.4%–
95.4%).
To determine prescription weight loss medication use,
respondents were asked, "In the past two years, have you
taken any weight loss pills prescribed by a doctor? Do not
include water pills or thyroid medications." Responses
were coded as: 1) "Yes, I am currently taking them", 2)
"Yes, I have taken them but I am not currently taking
them", or 3) "No, I have not taken them".
Respondents with a positive response were asked about
their prepill weight, "How much did you weigh just before
you started taking prescription weight loss pills for the
first time?"
At the end of the interview, respondents were asked to
report their current height and weight without shoes. We
used current weight and pretreatment weight to calculate
current and pretreatment body mass index (BMI), respec-
tively. BMI was calculated as weight (either current or pre-
treatment) in kilograms divided by current height in
meters squared. BMI was categorized into 3 groups: nor-
mal weight (<25.0), overweight (25.0–29.9), and obese
(≥ 30.0) [1]. Percent weight loss was defined as the differ-
ence between pretreatment body weight and current body
weight [pretreatment body weight minus current body
weight divided by pretreatment body weight times 100].
A 10% weight loss was used in the analyses as this is con-
sidered a reasonable individual initial weight loss goal by
current clinical guidelines [1]. We used a 6-item question
screener to assess the usual consumption of five or more
fruits and vegetables per day [13]. Respondent were asked,
1) "How often do you drink fruit juices such as orange,
grapefruit, or tomato? 2) Not counting juice, how often
do you eat fruit? 3) How often do you eat green salad? 4)
How often do you eat potatoes not including French fries,
fried potatoes, or potato chips? 5) How often do you eat
carrots?", And 6) "Not counting carrots, potatoes, or
salad, how many servings of vegetables do you usually
eat?"
We used the following questions to determine weight con-
trol strategy, "Are you now trying to lose weight?" Those
who responded "no" were then asked, "Are you now try-
ing to maintain your current weight, that is to keep from
gaining weight?" Additional questions on dietary prac-
tices and physical activity were asked of the subset of
respondents (95,100) who responded "yes" to trying to
lose or maintain their body weight. These respondents
were asked "Are you eating either fewer calories or less fat
to lose/maintain weight?" Their responses were either: 1)
"Yes, fewer calories", 2) "Yes, less fat", 3) "Yes, fewer calo-
ries and less fat", or 4) "No". They were also asked "AreInternational Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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you using physical activity or exercise to lose/maintain
weight? Their responses were either "yes" or "no".
All individuals were also asked "In the past 12 months,
has a doctor, nurse, or other health professional given you
advice about your weight?" Responses were "Yes, lose
weight", "Yes, gain weight", "Yes, maintain current
weight", "No". In an earlier section individuals were
asked, "About how long has it been since you last visited
a doctor for a routine checkup? The latter question was
used to distinguish those who had not received advice due
to not seeing a doctor for a routine checkup in the past 12
months.
For respondents who were currently using prescription
weight loss medication and were trying to lose weight or
maintain their current weight, we attempted to determine
if they were meeting the minimal lifestyle recommenda-
tions. Respondents who stated they were eating fewer cal-
ories – either as fewer calories or as both fewer calories
and less fat – were classified as meeting minimal dietary
recommendations. Respondents were asked about the
two physical activities or exercises they engage in most
often and about the frequency, duration, and distance (as
appropriate) of each activity [14]. Responses were then
classified as one of 56 selected activities. Moderate activity
was defined as any of the 56 selected activities, and vigor-
ous activity was defined as aerobic physical activity classi-
fied as vigorous-intensity based on estimated metabolic
expenditure (MET). To classify an activity as vigorous, it
must be aerobic with an assigned MET value that was at
least 60% of a person's maximal cardiorespiratory capac-
ity. To have achieved recommended levels of physical
activity, a person must have reported engaging in moder-
ate-intensity physical activity ≥ 5 times per week for ≥ 30
minutes each time, vigorous-intensity physical activity ≥ 3
times per week for ≥ 20 minutes each time, or both during
the preceding month. Persons reporting some activity dur-
ing the preceding month but not enough to be classified
as moderate or vigorous were classified as insufficient.
Persons classified as inactive reported no physical activity
outside of their occupation during the preceding month.
In addition to these activity categories, we calculated min-
utes per week of leisure-time (non-occupational) physical
activity levels.
We also requested demographic and socioeconomic
information such as age in years, sex, race/ethnicity, mar-
ital status, educational level, and household income. Of
the 149,806 respondents, we excluded those who did not
report information on prescription weight loss medica-
tion use (n = 1561), had a missing current weight (n =
5229) or height (n = 1369), were pregnant (n = 1780),
were missing current weight goal (trying to lose weight or
trying to maintain weight) (n = 749), or were missing
information on sociodemographic variables, fruit and
vegetable intake, or physical activity (n = 3595). We
excluded an additional 88 respondents that had a ques-
tionable reported weight, height or BMI that was outside
the sex-specific reference values from the Third National
Health and Nutrition Examination Survey, 1989–1994
[15]. The final study sample included a total of 135,435
respondents.
We used SAS and SUDAAN for the statistical analysis to
account for the complex sampling design [16,17]. Stu-
dent's t tests were used to test between-group differences
for means and chi-square tests were used to test between-
group differences for proportions. We set statistical signif-
icance at P < 0.05 for all comparisons. Multivariate logistic
regression analyses were carried out to examine independ-
ent predictors of our outcome measures including phar-
macotherapy use, 10% weight loss, and meeting diet and
physical activity recommendations. Models of pharmaco-
therapy use were stratified by sex and adjusted for age,
race/ethnicity, BMI, education level, household income,
marital status, and geographic region. Models of 10%
weight loss adjusted for sex, age, race/ethnicity, BMI, edu-
cation level, household income, marital status, geo-
graphic region, smoking status, usual fruit and vegetable
consumption, and past month leisure-time physical activ-
ity. Models of meeting both diet and physical activity rec-
ommendations adjusted for sex, age, race/ethnicity, BMI,
education level, household income, marital status, geo-
graphic region, and smoking status.
Results
The results of our multivariate analyses show that the
reported use of prescription weight loss medications in
the past 2 years was higher among women (4.0%) than
men (0.9%). For women, the odds of use was 19% lower
among those aged 35–54 years and 75% lower among
those 55 years old than among those aged <35 years. The
odds of prescription weight loss medication use was 34%
lower among non-Hispanic black women than among
non-Hispanic white women; and 53% and 39% lower
among those women residing in the Northeast and Mid-
west regions of the United States, respectively, than
among women residing in the West region (Table 1). We
also found the odds of prescription weight loss medica-
tion use was 62% higher among women with some col-
lege education than among those with less than a high
school education. For men, the odds of use was 62%
higher in Hispanics than among non-Hispanic whites.
Women who were obese had more than two times the
odds of prescription weight loss medication use com-
pared to women who were overweight and men who were
obese had more than six times the odds of use compared
to men who were overweight. In addition, women andInternational Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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men who had an annual household income of at least
$75,000 had more than two times the odds of prescrip-
tion weight loss medication use compared to those
respondents with an annual household income
<$20,000.
At the time of the survey, the average percentage of body
weight that was reported lost by prescription weight loss
medication users was 8.1% for women and 7.0% for men.
About one fifth of users gained weight (women: 19.8%,
men: 16.5%), one tenth lost no weight (women: 12.9%,
men: 13.4%), one-tenth lost between 1% and 5%
(women: 12.7%, men 21.0%), and one fifth lost between
5% and 9% of body weight (women: 19.6%, men:
24.1%), data not shown.
Table 1: Prevalence of Prescription Weight Loss Medication Use in the Previous 2 Years by Characteristics.
Women Men
(N = 78127) (N = 57308)
n % (SE) OR* (95% CI) n % (SE) OR* (95% CI)
Characteristic
Age group (yrs)
≥ 55 26787 1.61 (0.14) 0.25 (0.20–0.32) 16484 0.87 (0.13) 0.92 (0.58–1.47)
35–54 31256 5.54 (0.22) 0.81 (0.71–0.93) 24320 1.06 (0.09) 1.03 (0.73–1.45)
18–34 20084 4.80 (0.23) 1.00 16504 0.64 (0.10) 1.00
Race/ethnicity
Other 2613 2.80 (0.72) 0.69 (0.40–1.13) 2245 0.26 (0.10) 0.41 (0.20–0.86)
Hispanic 6248 5.31 (0.48) 1.12 (0.91–1.38) 4447 1.26 (0.27) 1.62 (1.02–2.57)
Non-Hispanic black 7086 3.90 (0.35) 0.66 (0.54–0.80) 4027 0.58 (0.15) 0.69 (0.40–1.19)
Non-Hispanic white 62180 3.93 (0.12) 1.00 46589 0.88 (0.07) 1.00
Body mass index (kg/m2)
≥ 30 14296 10.2 (0.42) 2.27 (1.98–2.60) 10566 3.11 (0.26) 6.24 (4.43–8.79)
25.0–29.9 22005 4.88 (0.23) 1.00 26036 0.51 (0.08) 1.00
<25.0 41826 1.45 (0.10) 0.24 (0.20–0.28) 20706 0.20 (0.04) 0.41 (0.24–0.69)
Education level
College graduate 19203 3.50 (0.23) 1.13 (0.86–1.48) 17525 0.92 (0.11) 1.00 (0.61–1.64)
Some college 22179 5.24 (0.25) 1.62 (1.28–2.06) 15151 0.93 (0.13) 1.04 (0.63–1.69)
High school 26614 3.83 (0.18) 1.26 (1.00–1.59) 17840 0.75 (0.10) 0.85 (0.52–1.39)
<High school 10026 3.00 (0.30) 1.00 6734 0.92 (0.19) 1.00
Household income
Don't know/refused 11947 2.14 (0.21) 0.88 (0.69–1.13) 6402 0.55 (0.18) 0.90 (0.42–1.95)
≥ $75,000 6859 5.13 (0.41) 2.06 (1.60–2.65) 7523 1.41 (0.19) 2.24 (1.38–3.62)
$50–74,999 9044 5.24 (0.38) 1.68 (1.34–2.10) 8690 1.03 (0.15) 1.51 (0.91–2.52)
$35–49,999 12108 5.19 (0.35) 1.54 (1.24–1.92) 10975 0.88 (0.16) 1.28 (0.75–2.19)
$20–34,999 19766 3.91 (0.22) 1.16 (0.97–1.39) 14929 0.68 (0.10) 0.99 (0.61–1.62)
<$20,000 18403 3.52 (0.24) 1.00 8789 0.72 (0.16) 1.00
Marital status†
Married 39608 4.28 (0.16) 0.90 (0.79–1.04) 33318 1.00 (0.08) 1.02 (0.74–1.42)
Not married 38428 3.72 (0.1) 1.00 23923 0.65 (0.09) 1.00
Geographic region
South 17887 5.11 (0.34) 0.90 (0.77–1.07) 14385 0.86 (0.17) 1.3 (0.83–2.04)
Northeast 26747 4.70 (0.18) 0.47 (0.37–0.60) 18007 1.11 (0.11) 0.85 (0.50–1.44)
Midwest 13508 2.32 (0.22) 0.61 (0.51–0.73) 10165 0.72 (0.12) 0.71 (0.44–1.15)
West 18524 3.48 (0.21) 1.00 13839 0.62 (0.08) 1.00
*Models are adjusted for age, race/ethnicity, body mass index, education level, household income, marital status, and geographic region.
†Marital status: respondents were classified as "not married if they were divorced, widowed, separated, never been married, member of an 
unmarried couple.International Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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Table 2: Prevalence of 10% Weight Loss Among Past 2 Year Users of Prescription Weight Loss Medication.
Characteristic n % (SE) OR* 95% CI
Sex
Men 497 25.0 (2.8) 0.63 (0.44–0.92)
Women 3012 35.0 (1.4) 1.00
Age group (yrs)
≥ 55 506 23.1 (2.9) 0.57 (0.38–0.85)
35–54 1927 34.0 (1.8) 0.95 (0.73–1.24)
18–34 1076 36.7 (2.3) 1.00
Race/ethnicity
Hispanic/other 350 30.4 (7.4) 0.77 (0.53–1.14)
Non-Hispanic black 258 35.2 (4.6) 0.76 (0.50–1.15)
Non-Hispanic white 2404 35.6 (1.6) 1.00
Pretreatment body mass index (kg/m2)
≥ 30 1799 45.5 (2.0) 2.24 (1.17–2.94)
25.0–29.9 269 27.2 (2.3) 1.00
<25.0 292 7.1 (1.7) 0.22 (0.13–0.38)
Education level
College graduate 675 33.1 (2.9) 1.00 (0.62–1.61)
Some college/tech 1106 37.2 (2.5) 1.16 (0.74–1.82)
High school 993 35.9 (2.4) 1.35 (0.89–2.06)
<High school 237 27.5 (4.4) 1.00
Household income
Don't know/refused 231 32.8 (5.1) 0.80 (0.46–1.37)
≥ $75,000 343 33.0 (3.9) 0.66 (0.41–1.06)
$50–74,999 467 33.4 (3.4) 0.65 (0.41–1.01)
$35–49,999 625 32.2 (3.1) 0.66 (0.44–1.00)
$20–34,999 800 36.5 (2.9) 0.82 (0.57–1.19)
<$20,000 564 39.9 (3.6) 1.00
Marital status
Married 1696 33.4 (1.8) 0.92 (0.70–1.21)
Not married 1314 37.4 (2.4) 1.00
Geographic region
South 1184 32.9 (1.8) 1.01 (0.74–1.39)
Northeast 243 30.9 (4.8) 0.91 (0.70–1.21)
Midwest 653 40.9 (3.2) 1.13 (0.79–1.64)
West 884 34.9 (3.3) 1.00
Smoking status
Current smoker 695 39.8 (3.2) 1.39 (1.04–1.86)
Former smoker 709 30.1 (2.8) 0.87 (0.65–1.17)
Never smoker 1608 34.7 (1.9) 1.00
Usual fruit and vegetable consumptionInternational Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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Additionally among users, one-third of women (35.0%)
and one quarter of men (25.0%) reported a 10% weight
loss, Table 2. The odds of having a 10% weight loss was
37% less among men than women and 43% less among
those 55 years old and older than among those 18–34
years. Those who were obese at pretreatment had more
than twice the odds of having a 10% weight loss com-
pared to those who were overweight. The odds of having
a 10% weight loss was 39% higher among those who were
current smokers compared to non-smokers. Those who
met minimal recommendations for leisure-time physical
activity had more than two twice the odds compared to
those who were inactive. The odds of a 10% weight loss
was 64% higher among those who usually consumed 5 or
more fruits and vegetables daily than among those who
usually consumed less than 3 fruits and vegetables a day.
Inclusion of weekly minutes of physical activity instead of
the meeting physical activity recommendations variable
into the 10% weight loss final model resulted in signifi-
cant odds ratios for individuals with 150–<320 minutes
odds ratio (OR) 1.50 (95% confidence interval (C.I.)
1.09–2.17), 320–<420 minutes OR 2.10 (95% C.I. 1.33–
3.31), and OR 1.61 (95% C.I. 0.98–2.64) compared to
those individuals reporting less than 150 minutes.
We also assessed professional advice, diet, and physical
activity among current prescription weight loss medica-
tion users by current weight intention (Table 3). Although
most of the respondents who reported current medication
use were trying to lose weight, 9% reported they were try-
ing to maintain weight. Examination of past year health
care professional advice about weight among those who
had seen a doctor for a routine checkup showed that
almost three quarters of those trying to lose weight had
been advised to lose weight. However, almost one-quarter
of current prescription weight loss medication users who
were trying to lose weight were given no advice about their
weight. Over half of users who were trying to maintain
their weight were given no advice about their weight.
Assessment of usual fruit and vegetable consumption
showed that about one quarter of those trying to lose
weight (28.3%) and one quarter of those trying to main-
tain their weight (27.6%) reported consuming 5 fruits and
vegetables a day. Almost two thirds of current prescription
weight loss medication users who reported they were try-
ing to lose weight reported reducing caloric consumption
(62.0%), 70.9% reported increasing physical activity, and
47.3% met physical activity recommendations. However,
these behaviors were reported less often in current pre-
scription weight loss medication users who reported they
were trying to maintain their weight, 39.6%, 49.6%, and
29.9%, respectively. A similar proportion of weekly
minute categories were observed among those trying to
lose weight and those trying to maintain weight, with
8.0% and 9.7% respectively, reporting at least 420 min-
utes per week.
Only one-quarter (26.7%) of current prescription weight
loss medication users met both lifestyle recommenda-
tions – eating fewer calories and attaining recommended
physical activity levels. Our results indicate that among
current users, the odds of meeting both recommendations
was 62% lower among men than among women and 56%
lower among other race/ethnic groups than among non-
Hispanic whites (Table 4). We also found that the odds of
meeting both recommendations was more than three
time higher among those with a household income of at
least $75,000 (OR 3.23) compared to those with a house-
hold income <$20,000 and those who usually consumed
5 or more fruits and vegetables a day had twice the odds
compared to < 3 fruits and vegetables a day. In a sensitiv-
ity analysis, we found that adding to this model past year
health professional advice about weight among those
who had a routine checkup (n = 559) did not appreciably
≥ 5 day 693 29.1 (3.1) 1.64 (1.19–2.27)
3–4 day 1205 35.4 (2.3) 1.16 (0.90–1.51)
<3 day 1114 30.2 (4.4) 1.00
Past month leisure-time physical activity†
Meeting recommendations 1331 42.9 (2.2) 2.19 (1.60–2.98)
Insufficient 834 30.3 (2.5) 1.16 (0.83–1.60)
Inactive 847 26.6 (2.7) 1.00
*Models are adjusted for sex, age, race/ethnicity, body mass index, education level, household income, marital status, geographic region, smoking 
status, usual fruit and vegetable consumption, and leisure-time physical activity in the past month.
†To have achieved recommended levels of physical activity, a person must have reported engaging in moderate-intensity physical activity ≥ 5 times 
per week for ≥ 30 minutes each time, vigorous-intensity physical activity ≥ 3 times per week for ≥ 20 minutes each time, or both during the 
preceding month [14].
Table 2: Prevalence of 10% Weight Loss Among Past 2 Year Users of Prescription Weight Loss Medication. (Continued)International Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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change the results and that advice to lose weight was not
an independent predictor of meeting both recommenda-
tions (OR = 1.37, 95% C.I. 0.73–2.56).
In a secondary analyses we assessed prevalence of a 10%
weight loss among current prescription weight loss medi-
cation users who were trying to lose weight (not main-
tain) by whether or not recommendations were met for
eating fewer calories and physical activity (n = 237).
39.6% (SE 5.3) of individuals who reported both eating
fewer calories and who met physical activity recommen-
dations had lost at least 10% of their pretreatment weight;
36.5% (SE 6.4) who reported eating fewer calories but
who did not meet the physical activity recommendations
had lost at least 10% of their pretreatment weight; 54.3%
(SE 9.8) who reported not eating fewer calories but met
physical activity recommendations had lost at least 10%
of their pretreatment weight; and 25.5% (SE 5.9) who did
not meet either lifestyle recommendation had lost at least
10% of their pretreatment weight, (chi-square p = 0.03).
Discussion
Although in 1998 clinical guidelines recommended that
prescription medication for obesity be used in conjunc-
tion with lifestyle modifications [1], we found that during
that same year only one quarter of current prescription
weight loss medication users reported minimal diet (eat-
ing fewer calories) and physical activity behaviors recom-
mended for weight loss. Our analyses indicated that
meeting these recommendations was low across all socio-
demographic groups (<40%) and, men were less likely to
meet recommendations compared to women.
Although patterns of prescription medication use differed
by sex, for both men and women the odds of use was
higher among those who were obese compared to those
Table 3: Prevalence of Professional Advice, Diet, and Physical Activity Behaviors Among Current Users of Prescription Weight Loss 
Medication.
Current Weight Management Intention
Lose Weight Maintain Weight Total
(n = 563) (n = 59) (n = 622)
% (SE) % (SE) % (SE)
Health professional past year 
weight advice*
Lose weight 73.9 (3.6) 35.6 (10.7) 71.0 (3.4)
Maintain weight 1.9 (0.6) 7.2 (5.2) 2.5 (0.7)
Gain weight 0.1 (0.1) 0.0 (0.0) 0.3 (0.2)
No advice 24.1 (3.5) 57.2 (10.6) 26.3 (3.3)
Diet
Fewer calories for weight 
control
62.0 (3.2) 39.6 (7.5) 60.2 (3.0)
≥ 5 fruits and vegetables daily 28.3 (3.4) 27.6 (7.7) 28.2 (3.1)
Physical activity
Increased physical activity
for weight control 70.9 (3.4) 49.6 (9.3) 69.1 (3.2)
Past month
Inactive 25.1 (3.5) 47.9 (9.5) 27.0 (3.3)
Insufficient 27.6 (3.3) 22.2 (7.1) 27.2 (3.1)
Meeting recommendations** 47.3 (3.8) 29.9 (7.7) 45.8 (3.5)
Past month (weekly minutes)
<150 minutes 53.0 (4.1) 58.4 (11.1) 52.1 (3.9
150–<320 minutes 27.9 (3.8) 20.2 (8.0) 27.5 (3.5)
320–<420 minutes 11.1 (2.8) 11.7 (5.6) 11.1 (2.6)
≥ 420 minutes 8.0 (1.9) 9.7 (7.1) 9.4 (1.9)
*Among those who reported that had visited a doctor for a routine checkup in the past 12 months (n = 514).
*†To have achieved recommended levels of physical activity, a person must have reported engaging in moderate-intensity physical activity ≥ 5 times 
per week for ≥ 30 minutes each time, vigorous-intensity physical activity ≥ 3 times per week for ≥ 20 minutes each time, or both during the 
preceding month [14].International Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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who were overweight although at different magnitudes.
Our data show than more overweight women used pre-
scription weight loss medications (4.88%) than did obese
men (3.11%). It is possible that pharmacotherapy pre-
scribing patterns differ by sex since more women than
men attempt weight loss [10] or that for men, a higher
BMI is needed before personal action regarding weight is
taken.
Eating fruits and vegetables and taking part in recom-
mended levels of physical activity through leisure-time
activities were more frequent behaviors among
prescription weight loss medications users who had lost at
least 10% of their body weight. Although we had no direct
measurements of caloric intake, fruits and vegetables in
their natural state are low in energy density. Thus, adding
or substituting fruits and vegetables for energy-dense
Table 4: Meeting diet (fewer calories) and Physical Activity Recommendations* Among Current Users of Prescription Weight Loss 
Medication.
Characteristic n Total (SE) OR† 95% CI
Sex
Men 98 14.8 (4.4) 0.38 (0.17–0.84)
Women 524 29.7 (3.3) 1.00
Age group (yr)
≥ 55 91 21.6 (6.9) 0.92 (0.34–2.46)
35–54 338 29.5 (4.1) 1.10 (0.58–2.11)
18–34 193 25.7 (4.1) 1.00
Race/ethnicity
Other 154 16.9 (4.8) 0.44 (0.20–0.96)
Non-Hispanic white 468 32.1 (3.4) 1.00
Pretreatment body mass index (kg/
m2)
≥ 30.0 403 25.7 (3.1) 1.02 (0.54–1.91)
<30.0 187 28.8 (6.0) 1.00
Education level
College graduate 147 29.8 (6.4) 1.78 (0.76–4.15)
Some college/tech 201 34.7 (5.1) 1.97 (1.00–3.90)
<High school 274 19.7 (4.0) 1.00
Household income
≥ $75,000 91 39.0 (7.4) 3.23 (1.18–8.83)
$50–74,999 80 29.0 (2.9) 2.49 (0.85–7.25)
$35–49,999 140 32.4 (5.9) 2.45 (0.82–7.35)
$20–34,999 157 27.1 (4.7) 2.14 (0.89–5.14)
<$20,000‡ 154 14.9 (3.9) 1.00
Marital status
Married 370 28.0 (4.9) 0.87 (0.47–1.59)
Not married 252 24.6 (4.0) 1.00
Geographic region
South 241 27.6 (4.0) 0.78 (0.34–1.78)
Midwest/Northeast 189 26.1 (4.3) 1.03 (0.45–2.32)
West 159 26.5 (6.3) 1.00
Usual fruit and vegetable 
consumption
≥ 5 day 158 34.7 (6.4) 2.30 (1.05–5.03)
3–4 day 227 26.3 (4.1) 1.30 (0.67–2.53)
<3 day 237 21.3 (3.8) 1.00
Smoking
Current smoker 149 31.5 (6.6) 1.78 (0.94–3.36)
Former smoker 146 26.4 (5.5) 1.10 (0.54–2.26)
Never smoker 327 24.3 (3.3) 1.00
*To have achieved recommended levels of physical activity, a person must have reported engaging in moderate-intensity physical activity ≥ 5 times 
per week for ≥ 30 minutes each time, vigorous-intensity physical activity ≥ 3 times per week for ≥ 20 minutes each time, or both during the 
preceding month [14].
†Models are adjusted for sex, age, race/ethnicity, body mass index, education level, household income, marital status, geographic region, smoking 
status, and usual fruit and vegetable consumption.
‡Includes "Don't know" and "Refused" annual household income responses.International Journal of Behavioral Nutrition and Physical Activity 2004, 1:17 http://www.ijbnpa.org/content/1/1/17
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snacks and sweets can impact satiety and weight gain
[2,18,19]. Our analyses also indicate that those respond-
ents who met the minimal recommendations for leisure-
time physical activity had twice the odds of having lost
10% of their body weight compared to those who were
sedentary. We observed higher odds of 10% weight loss
for those with at least 150 weekly minutes, but the magni-
tude did not appear to have a dose effect. We believe addi-
tional research is needed to determine whether physical
activity modifications require greater duration, such as
exercising 60 minutes or more daily to prevent weight
regain as has been suggested by the Institute of Medicine
[20], to improve the efficacy of currently approved obesity
pharmacotherapy for weight management.
About 40% of current prescription weight loss medica-
tions users who both reduced calories and met leisure-
time physical activity recommendations had lost 10% of
their body weight. Our data also show that respondents
who consumed usually less than 5 fruits and vegetables
per day were less likely to meet both diet and physical
activity recommendations than did those who consumed
5 or more fruits and vegetables a day. Because fewer than
half of physicians counsel obese patients about weight
control [21,22] we believe the opportunity exists for phy-
sicians and other health care professionals to provide
counseling that emphasizes appropriate weight control
practices that include regular physical activity and a bal-
anced low-calorie diet which includes increasing con-
sumption of fruits and vegetables.
The current study had several limitations. Although the
participants self-reported pre-medication body weight
and current weight, we did not ask for the date prescrip-
tion weight loss medication use began and it could not be
established whether weight loss was solely attributable to
pharmacotherapy usage. We were also unable to deter-
mine if respondents had lost a substantial amount of
weight but then regained the weight (weight history). Self-
reported weights and weight history may also be a con-
cern because individuals, especially those who are over-
weight, may underreport their weight [23]. We lacked
dietary assessment measures to quantify the number of
calories consumed. Thus, we could not determine
whether individuals had actually reduced their caloric
consumption to levels that would lead to substantial
weight loss. Research suggests that some obese subjects
underestimate their caloric intake and overestimate their
physical activity [24]. In addition, we lacked data on
whether respondents were counseled specifically about
physical activity and/or nutrition for weight management
or had undergone behavioral therapy.
Although we found that about one fifth of participants
had lost between 5% and 9% of their pretreatment body
weight and one third of participants had lost at least 10%
of their pretreatment body weight, the pill dosage and
length of medication use were not collected. Thus, some
users may have used pills for a short time, such as less
than 6 months, and would not be expected to have lost
5% to 10% of their body weight.
In current practice, physicians treating obesity can pre-
scribe phentermine, sibutramine, and orlistat (available
April 1999). Analysis of national data on patient visits
found that phentermine was the most common antiobes-
ity medication in 2001 and in early 2002 (based on Janu-
ary through March figures) [25], suggesting that our data,
although collected in 1998, has relevance to current
weight management.
Most nonsurgical obesity treatments lead to weight loss
for the first 6 months followed by regain [26]. Thus, some
health care professionals suggest that prescription weight
loss medication be prescribed either to enhance weight
loss during the active weight-loss phase or to prevent later
regain [26,27]. In our study, 9% of current medication
users reported that they were currently trying to maintain
their weight. We observed that the behaviors of these indi-
viduals differed from those who said they were currently
trying to lose weight, e.g. fewer reported eating less calo-
ries, fewer met physical-activity recommendations, and
fewer were advised by a health care professional to either
lose or maintain weight. Additional research is needed on
use of pharmacotherapy for weight maintenance.
Conclusions
We found that one in ten obese women and one in 33
obese men reported using a prescription weight loss med-
ication in the past two years. Among medication users,
one-third of women and one quarter of men reported a
10% weight loss. Only one quarter of current medication
users reported the minimal diet and physical activity
behaviors recommended for weight loss. Ongoing popu-
lation-based surveillance is needed to assess the preva-
lence of prescription weight loss medication use and
whether pharmacotherapy users are making appropriate
lifestyle changes in order to lose or maintain weight.
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